Atlas Trials

Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study

Clinical trial NCT06094231 · TERMINATED

Trial details

NCT number
NCT06094231
Sponsor
Department of Nephrology Clinic Ottakring Vienna
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Kidney DiseasesDiabetes MellitusPreDiabetesOverweight and Obesity
Start date
2023-09-25
Primary completion
2026-04-13
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.